Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Total Non-Current Liabilities (2016)

Protara Therapeutics' Total Non-Current Liabilities history spans 2 years, with the latest figure at $4.8 million for Q3 2016.

  • Quarterly Total Non-Current Liabilities rose 52.9% to $4.8 million in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Sep 2016, up 52.9% year-over-year, with the annual reading at $3.6 million for FY2015, N/A changed from the prior year.
  • Total Non-Current Liabilities came in at $4.8 million for Q3 2016, up from $4.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $4.8 million in Q3 2016 to a low of $2.8 million in Q2 2015.